Literature DB >> 9036102

[Myositis--a rare complication of Crohn disease].

A Druschky1, J Heckmann, A Engelhardt.   

Abstract

Crohn's disease is a chronic relapsing inflammatory disorder primarily affecting the gastrointestinal system. Extraintestinal manifestations such as erythema nodosum, iridocyclitis, arthritis and sclerosing cholangitis are frequent. We report on a 57-year old male patient with the symptoms of Crohn's disease. Clinically he showed signs of a muscle disorder and muscle biopsy demonstrated a perimysial inflammation with lymphocytes and histiocytes. Complete remission was achieved by immunosuppressive treatment. Six cases presented in the literature are reviewed and the autoimmunological aspects of the pathogenesis discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9036102     DOI: 10.1055/s-2007-996586

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  4 in total

Review 1.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 2.  Neurological disorders and inflammatory bowel diseases.

Authors:  Giovanni Casella; Gian Eugenio Tontini; Gabrio Bassotti; Luca Pastorelli; Vincenzo Villanacci; Luisa Spina; Vittorio Baldini; Maurizio Vecchi
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

3.  Association of idiopathic inflammatory myopathy and Crohn's disease.

Authors:  N Szabo; Sz Lukacs; I Kulcsar; W Gunasekera; A Nagy-Toldi; B Dezso; K Danko
Journal:  Clin Rheumatol       Date:  2008-11-11       Impact factor: 2.980

4.  Gastrocnemius Myalgia as a Rare Initial Manifestation of Crohn's Disease.

Authors:  Atsumu Osada; Hiroaki Yamada; Sayuri Takehara; Yuuichiro Tozuka; Taito Fukushima; Hiroyuki Oka; Hiroshi Okazaki; Shohei Nagaoka
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.